|  Help  |  About  |  Contact Us

Search our database by keyword

- or -

Examples

  • Search this entire website. Enter identifiers, names or keywords for genes, diseases, strains, ontology terms, etc. (e.g. Pax6, Parkinson, ataxia)
  • Use OR to search for either of two terms (e.g. OR mus) or quotation marks to search for phrases (e.g. "dna binding").
  • Boolean search syntax is supported: e.g. Balb* for partial matches or mus AND NOT embryo to exclude a term

Search results 901 to 1000 out of 1941 for MAPT

Category restricted to Publication (x)

<< First    < Previous  |  Next >    Last >>
0.029s

Categories

Category: Publication
« show all
Type Details Score
Publication
29860433 | J:264570
First Author: Tapias V
Year: 2018
Journal: Hum Mol Genet
Title: Benfotiamine treatment activates the Nrf2/ARE pathway and is neuroprotective in a transgenic mouse model of tauopathy.
Volume: 27
Issue: 16
Pages: 2874-2892
•
•
•
•
•
Publication
37925173 | J:343127
First Author: Cao Q
Year: 2023
Journal: Aging (Albany NY)
Title: Longitudinal characterization of behavioral, morphological and transcriptomic changes in a tauopathy mouse model.
Volume: 15
Issue: 21
Pages: 11697-11719
•
•
•
•
•
Publication
36344699 | J:355376
First Author: Martinez P
Year: 2022
Journal: Nat Neurosci
Title: Bassoon contributes to tau-seed propagation and neurotoxicity.
Volume: 25
Issue: 12
Pages: 1597-1607
•
•
•
•
•
Publication
37569786 | J:355377
 
First Author: GĂ©raudie A
Year: 2023
Journal: Int J Mol Sci
Title: Effects of Low-Intensity Pulsed Ultrasound-Induced Blood-Brain Barrier Opening in P301S Mice Modeling Alzheimer's Disease Tauopathies.
Volume: 24
Issue: 15
•
•
•
•
•
Publication
38691615 | J:348999
First Author: Hou K
Year: 2024
Journal: Sci Adv
Title: D-peptide-magnetic nanoparticles fragment tau fibrils and rescue behavioral deficits in a mouse model of Alzheimer's disease.
Volume: 10
Issue: 18
Pages: eadl2991
•
•
•
•
•
Publication
37865996 | J:355380
 
First Author: Collu R
Year: 2023
Journal: Biomed Pharmacother
Title: Angiotensin-converting enzyme inhibitors and statins therapies-induced changes in omics profiles in humans and transgenic tau mice.
Volume: 168
Pages: 115756
•
•
•
•
•
Publication
32891185 | J:311714
First Author: Yang T
Year: 2020
Journal: Acta Neuropathol Commun
Title: Small-molecule modulation of the p75 neurotrophin receptor inhibits a wide range of tau molecular pathologies and their sequelae in P301S tauopathy mice.
Volume: 8
Issue: 1
Pages: 156
•
•
•
•
•
Publication
34453888 | J:315841
First Author: Jiang L
Year: 2021
Journal: Mol Cell
Title: Interaction of tau with HNRNPA2B1 and N6-methyladenosine RNA mediates the progression of tauopathy.
Volume: 81
Issue: 20
Pages: 4209-4227.e12
•
•
•
•
•
Publication
21825035 | J:178410
First Author: Dumont M
Year: 2011
Journal: FASEB J
Title: Behavioral deficit, oxidative stress, and mitochondrial dysfunction precede tau pathology in P301S transgenic mice.
Volume: 25
Issue: 11
Pages: 4063-72
•
•
•
•
•
Publication
26364736 | J:232244
First Author: Jiang T
Year: 2015
Journal: Neurobiol Aging
Title: Silencing of TREM2 exacerbates tau pathology, neurodegenerative changes, and spatial learning deficits in P301S tau transgenic mice.
Volume: 36
Issue: 12
Pages: 3176-3186
•
•
•
•
•
Publication
38980136 | J:355477
 
First Author: Burke K
Year: 2024
Journal: JASA Express Lett
Title: Auditory brainstem response audiometry in tauopathy mouse model of human Alzheimer's disease.
Volume: 4
Issue: 7
•
•
•
•
•
Publication
32611392 | J:294864
First Author: Tang SJ
Year: 2020
Journal: Acta Neuropathol Commun
Title: Fyn kinase inhibition reduces protein aggregation, increases synapse density and improves memory in transgenic and traumatic Tauopathy.
Volume: 8
Issue: 1
Pages: 96
•
•
•
•
•
Publication
36794623 | J:355484
First Author: Rimal S
Year: 2023
Journal: EMBO Rep
Title: Reverse electron transfer is activated during aging and contributes to aging and age-related disease.
Volume: 24
Issue: 4
Pages: e55548
•
•
•
•
•
Publication
36917493 | J:355485
   
First Author: Cecon E
Year: 2023
Journal: Elife
Title: Novel repertoire of tau biosensors to monitor pathological tau transformation and seeding activity in living cells.
Volume: 12
•
•
•
•
•
Publication
35136118 | J:322536
First Author: Perea JR
Year: 2022
Journal: Sci Rep
Title: p38 activation occurs mainly in microglia in the P301S Tauopathy mouse model.
Volume: 12
Issue: 1
Pages: 2130
•
•
•
•
•
Publication
38915105 | J:360323
First Author: Parra Bravo C
Year: 2024
Journal: Mol Neurodegener
Title: Anti-acetylated-tau immunotherapy is neuroprotective in tauopathy and brain injury.
Volume: 19
Issue: 1
Pages: 51
•
•
•
•
•
Publication
38517786 | J:355490
First Author: Cogut V
Year: 2024
Journal: J Alzheimers Dis
Title: Caloric Restriction Improves Spatial Learning Deficits in Tau Mice.
Volume: 98
Issue: 3
Pages: 925-940
•
•
•
•
•
Publication
29982852 | J:315887
First Author: El Fatimy R
Year: 2018
Journal: Acta Neuropathol
Title: MicroRNA-132 provides neuroprotection for tauopathies via multiple signaling pathways.
Volume: 136
Issue: 4
Pages: 537-555
•
•
•
•
•
Publication
28123067 | J:269141
 
First Author: DeVos SL
Year: 2017
Journal: Sci Transl Med
Title: Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.
Volume: 9
Issue: 374
•
•
•
•
•
Publication
36001963 | J:351228
First Author: Prissette M
Year: 2022
Journal: Cell Rep
Title: Disruption of nuclear envelope integrity as a possible initiating event in tauopathies.
Volume: 40
Issue: 8
Pages: 111249
•
•
•
•
•
Publication
31664089 | J:284244
First Author: Hovakimyan A
Year: 2019
Journal: Sci Rep
Title: A MultiTEP platform-based epitope vaccine targeting the phosphatase activating domain (PAD) of tau: therapeutic efficacy in PS19 mice.
Volume: 9
Issue: 1
Pages: 15455
•
•
•
•
•
Publication
38715400 | J:355502
First Author: Yoo CJ
Year: 2024
Journal: FEBS J
Title: Complement receptor 4 mediates the clearance of extracellular tau fibrils by microglia.
Volume: 291
Issue: 15
Pages: 3499-3520
•
•
•
•
•
Publication
32334108 | J:289412
 
First Author: Schweig JE
Year: 2020
Journal: Neurosci Lett
Title: Neuronal Spleen tyrosine kinase (SYK) mediates cytokine release in Transgenic Tau P301S mice organotypic brain slice cultures.
Volume: 729
Pages: 134992
•
•
•
•
•
Publication
37759245 | J:355508
First Author: Wang P
Year: 2023
Journal: Cell Biosci
Title: PI3K-AKT activation resculpts integrin signaling to drive filamentous tau-induced proinflammatory astrogliosis.
Volume: 13
Issue: 1
Pages: 179
•
•
•
•
•
Publication
36609445 | J:340158
First Author: Williams JB
Year: 2023
Journal: Nat Commun
Title: Inhibition of histone methyltransferase Smyd3 rescues NMDAR and cognitive deficits in a tauopathy mouse model.
Volume: 14
Issue: 1
Pages: 91
•
•
•
•
•
Publication
37175376 | J:359525
 
First Author: Zhong S
Year: 2023
Journal: Molecules
Title: Quercetagitrin Inhibits Tau Accumulation and Reverses Neuroinflammation and Cognitive Deficits in P301S-Tau Transgenic Mice.
Volume: 28
Issue: 9
•
•
•
•
•
Publication
37771520 | J:347834
 
First Author: Yu H
Year: 2023
Journal: Front Aging Neurosci
Title: The Îł-Adducin 1-357 fragment promotes tau pathology.
Volume: 15
Pages: 1241750
•
•
•
•
•
Publication
28424326 | J:252111
 
First Author: Yanamandra K
Year: 2017
Journal: Sci Transl Med
Title: Anti-tau antibody administration increases plasma tau in transgenic mice and patients with tauopathy.
Volume: 9
Issue: 386
•
•
•
•
•
Publication
34326423 | J:321289
First Author: Onishi T
Year: 2021
Journal: Sci Rep
Title: A novel orally active HDAC6 inhibitor T-518 shows a therapeutic potential for Alzheimer's disease and tauopathy in mice.
Volume: 11
Issue: 1
Pages: 15423
•
•
•
•
•
Publication
36631898 | J:332525
First Author: Arouche-Delaperche L
Year: 2023
Journal: Acta Neuropathol Commun
Title: Dysfunction of the glutamatergic photoreceptor synapse in the P301S mouse model of tauopathy.
Volume: 11
Issue: 1
Pages: 5
•
•
•
•
•
Publication
36092812 | J:328922
 
First Author: Cazzaro S
Year: 2022
Journal: Front Aging Neurosci
Title: Slingshot homolog-1 mediates the secretion of small extracellular vesicles containing misfolded proteins by regulating autophagy cargo receptors and actin dynamics.
Volume: 14
Pages: 933979
•
•
•
•
•
Publication
37622125 | J:347970
 
First Author: Zupancic JM
Year: 2023
Journal: Front Immunol
Title: Quantitative flow cytometric selection of tau conformational nanobodies specific for pathological aggregates.
Volume: 14
Pages: 1164080
•
•
•
•
•
Publication
25132556 | J:258966
 
First Author: Koga S
Year: 2014
Journal: Neurobiol Dis
Title: Effects of diet-induced obesity and voluntary exercise in a tauopathy mouse model: implications of persistent hyperleptinemia and enhanced astrocytic leptin receptor expression.
Volume: 71
Pages: 180-92
•
•
•
•
•
Publication
38206965 | J:344474
First Author: Zhang X
Year: 2024
Journal: PLoS Biol
Title: Bridging integrator 1 fragment accelerates tau aggregation and propagation by enhancing clathrin-mediated endocytosis in mice.
Volume: 22
Issue: 1
Pages: e3002470
•
•
•
•
•
Publication
28188247 | J:252831
First Author: Lang SC
Year: 2017
Journal: J Immunol
Title: Neurodegeneration Enhances the Development of Arthritis.
Volume: 198
Issue: 6
Pages: 2394-2402
•
•
•
•
•
Publication
29304088 | J:257794
First Author: Lecocq S
Year: 2018
Journal: PLoS One
Title: Aptamers as biomarkers for neurological disorders. Proof of concept in transgenic mice.
Volume: 13
Issue: 1
Pages: e0190212
•
•
•
•
•
Publication
37043557 | J:336375
First Author: Eteläinen TS
Year: 2023
Journal: Sci Transl Med
Title: A prolyl oligopeptidase inhibitor reduces tau pathology in cellular models and in mice with tauopathy.
Volume: 15
Issue: 691
Pages: eabq2915
•
•
•
•
•
Publication
36001972 | J:344140
First Author: Pandey S
Year: 2022
Journal: Cell Rep
Title: Disease-associated oligodendrocyte responses across neurodegenerative diseases.
Volume: 40
Issue: 8
Pages: 111189
•
•
•
•
•
Publication
28416651 | J:242003
First Author: Ising C
Year: 2017
Journal: J Exp Med
Title: AAV-mediated expression of anti-tau scFvs decreases tau accumulation in a mouse model of tauopathy.
Volume: 214
Issue: 5
Pages: 1227-1238
•
•
•
•
•
Publication
31156179 | J:355608
First Author: Liu M
Year: 2019
Journal: J Alzheimers Dis
Title: Inhibition of Calpain Protects Against Tauopathy in Transgenic P301S Tau Mice.
Volume: 69
Issue: 4
Pages: 1077-1087
•
•
•
•
•
Publication
39133647 | J:355614
 
First Author: Liu C
Year: 2024
Journal: JCI Insight
Title: PM2.5 triggers tau aggregation in a mouse model of tauopathy.
Volume: 9
Issue: 14
•
•
•
•
•
Publication
29245902 | J:355620
First Author: Wang Y
Year: 2017
Journal: Oncotarget
Title: COX-2 metabolic products, the prostaglandin I(2) and F(2α), mediate the effects of TNF-α and Zn(2+) in stimulating the phosphorylation of Tau.
Volume: 8
Issue: 59
Pages: 99296-99311
•
•
•
•
•
Publication
34731014 | J:333616
First Author: Barker SJ
Year: 2021
Journal: Sci Transl Med
Title: MEF2 is a key regulator of cognitive potential and confers resilience to neurodegeneration.
Volume: 13
Issue: 618
Pages: eabd7695
•
•
•
•
•
Publication
30604097 | J:355622
First Author: Vemula P
Year: 2019
Journal: Amino Acids
Title: Altered brain arginine metabolism in a mouse model of tauopathy.
Volume: 51
Issue: 3
Pages: 513-528
•
•
•
•
•
Publication
28234253 | J:355617
First Author: Li Y
Year: 2017
Journal: J Alzheimers Dis
Title: Tau Pathology Promotes the Reorganization of the Extracellular Matrix and Inhibits the Formation of Perineuronal Nets by Regulating the Expression and the Distribution of Hyaluronic Acid Synthases.
Volume: 57
Issue: 2
Pages: 395-409
•
•
•
•
•
Publication
30392797 | J:274921
First Author: Dejanovic B
Year: 2018
Journal: Neuron
Title: Changes in the Synaptic Proteome in Tauopathy and Rescue of Tau-Induced Synapse Loss by C1q Antibodies.
Volume: 100
Issue: 6
Pages: 1322-1336.e7
•
•
•
•
•
Publication
33586680 | J:355626
 
First Author: Sandusky-Beltran LA
Year: 2021
Journal: J Clin Invest
Title: Aberrant AZIN2 and polyamine metabolism precipitates tau neuropathology.
Volume: 131
Issue: 4
•
•
•
•
•
Publication
37562846 | J:339351
 
First Author: Drieu A
Year: 2023
Journal: Life Sci Alliance
Title: Parenchymal border macrophages regulate tau pathology and tau-mediated neurodegeneration.
Volume: 6
Issue: 11
•
•
•
•
•
Publication
25331948 | J:338736
First Author: Paris D
Year: 2014
Journal: J Biol Chem
Title: The spleen tyrosine kinase (Syk) regulates Alzheimer amyloid-β production and Tau hyperphosphorylation.
Volume: 289
Issue: 49
Pages: 33927-44
•
•
•
•
•
Publication
28083634 | J:309817
First Author: Wang P
Year: 2017
Journal: Acta Neuropathol
Title: Tau interactome mapping based identification of Otub1 as Tau deubiquitinase involved in accumulation of pathological Tau forms in vitro and in vivo.
Volume: 133
Issue: 5
Pages: 731-749
•
•
•
•
•
Publication
37865646 | J:342080
First Author: Zhang X
Year: 2023
Journal: Nat Commun
Title: Soluble TREM2 ameliorates tau phosphorylation and cognitive deficits through activating transgelin-2 in Alzheimer's disease.
Volume: 14
Issue: 1
Pages: 6670
•
•
•
•
•
Publication
39794315 | J:361224
First Author: Zheng N
Year: 2025
Journal: Transl Psychiatry
Title: Electrophysiology-based screening identifies neuronal HtrA serine peptidase 2 (HTRA2) as a synaptic plasticity regulator participating in tauopathy.
Volume: 15
Issue: 1
Pages: 5
•
•
•
•
•
Publication
39806423 | J:361223
First Author: Ye J
Year: 2025
Journal: Mol Neurodegener
Title: Upregulated astrocyte HDAC7 induces Alzheimer-like tau pathologies via deacetylating transcription factor-EB and inhibiting lysosome biogenesis.
Volume: 20
Issue: 1
Pages: 5
•
•
•
•
•
Publication
36657633 | J:344595
 
First Author: Perez-Garcia G
Year: 2023
Journal: Neurosci Lett
Title: BCI-838, an orally active mGluR2/3 receptor antagonist pro-drug, rescues learning behavior deficits in the PS19 MAPT(P301S) mouse model of tauopathy.
Volume: 797
Pages: 137080
•
•
•
•
•
Publication
37446327 | J:337950
 
First Author: Vallés-Saiz L
Year: 2023
Journal: Int J Mol Sci
Title: Lamivudine (3TC), a Nucleoside Reverse Transcriptase Inhibitor, Prevents the Neuropathological Alterations Present in Mutant Tau Transgenic Mice.
Volume: 24
Issue: 13
•
•
•
•
•
Publication
36495262 | J:355709
First Author: Cascella R
Year: 2023
Journal: Ann Med
Title: An in situ and in vitro investigation of cytoplasmic TDP-43 inclusions reveals the absence of a clear amyloid signature.
Volume: 55
Issue: 1
Pages: 72-88
•
•
•
•
•
Publication
36422837 | J:355708
First Author: Zhao S
Year: 2023
Journal: Neurotherapeutics
Title: Metformin Attenuates Tau Pathology in Tau-Seeded PS19 Mice.
Volume: 20
Issue: 2
Pages: 452-463
•
•
•
•
•
Publication
32093751 | J:299834
First Author: Sun Y
Year: 2020
Journal: J Neuroinflammation
Title: The behavioural and neuropathologic sexual dimorphism and absence of MIP-3α in tau P301S mouse model of Alzheimer's disease.
Volume: 17
Issue: 1
Pages: 72
•
•
•
•
•
Publication
22922230 | J:188924
First Author: Dumont M
Year: 2012
Journal: Hum Mol Genet
Title: Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice.
Volume: 21
Issue: 23
Pages: 5091-105
•
•
•
•
•
Publication
24857020 | J:221275
First Author: Sanders DW
Year: 2014
Journal: Neuron
Title: Distinct tau prion strains propagate in cells and mice and define different tauopathies.
Volume: 82
Issue: 6
Pages: 1271-88
•
•
•
•
•
Publication
29133432 | J:253606
First Author: Chalermpalanupap T
Year: 2018
Journal: J Neurosci
Title: Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
Volume: 38
Issue: 1
Pages: 74-92
•
•
•
•
•
Publication
29607621 | J:261849
First Author: Giannopoulos PF
Year: 2018
Journal: Aging Cell
Title: Antileukotriene therapy by reducing tau phosphorylation improves synaptic integrity and cognition of P301S transgenic mice.
Volume: 17
Issue: 3
Pages: e12759
•
•
•
•
•
Publication
24556215 | J:210668
First Author: Stack C
Year: 2014
Journal: Hum Mol Genet
Title: Methylene blue upregulates Nrf2/ARE genes and prevents tau-related neurotoxicity.
Volume: 23
Issue: 14
Pages: 3716-32
•
•
•
•
•
Publication
32968279 | J:297414
First Author: Xu D
Year: 2020
Journal: Nature
Title: Modulating TRADD to restore cellular homeostasis and inhibit apoptosis.
Volume: 587
Issue: 7832
Pages: 133-138
•
•
•
•
•
Publication
39095921 | J:361342
First Author: Li LJ
Year: 2024
Journal: Transl Neurodegener
Title: Neuronal double-stranded DNA accumulation induced by DNase II deficiency drives tau phosphorylation and neurodegeneration.
Volume: 13
Issue: 1
Pages: 39
•
•
•
•
•
Publication
37703352 | J:360029
First Author: Zhao X
Year: 2023
Journal: Sci Transl Med
Title: A microtubule stabilizer ameliorates protein pathogenesis and neurodegeneration in mouse models of repetitive traumatic brain injury.
Volume: 15
Issue: 713
Pages: eabo6889
•
•
•
•
•
Publication
27743524 | J:239626
 
First Author: Soler H
Year: 2017
Journal: Neurobiol Aging
Title: The GABAergic septohippocampal connection is impaired in a mouse model of tauopathy.
Volume: 49
Pages: 40-51
•
•
•
•
•
Publication
21907761 | J:182782
 
First Author: Llorens-Martin M
Year: 2011
Journal: Neuroscience
Title: Expression of frontotemporal dementia with parkinsonism associated to chromosome 17 tau induces specific degeneration of the ventral dentate gyrus and depressive-like behavior in mice.
Volume: 196
Pages: 215-27
•
•
•
•
•
Publication
23774255 | J:201700
 
First Author: GarcĂ­a-Cabrero AM
Year: 2013
Journal: Neurobiol Dis
Title: Hyperexcitability and epileptic seizures in a model of frontotemporal dementia.
Volume: 58
Pages: 200-8
•
•
•
•
•
Publication
31133559 | J:278231
First Author: Terreros-Roncal J
Year: 2019
Journal: J Neurosci
Title: Activity-Dependent Reconnection of Adult-Born Dentate Granule Cells in a Mouse Model of Frontotemporal Dementia.
Volume: 39
Issue: 29
Pages: 5794-5815
•
•
•
•
•
Publication
21530001 | J:188211
First Author: Silveyra MX
Year: 2012
Journal: Neurobiol Aging
Title: Altered expression of brain acetylcholinesterase in FTDP-17 human tau transgenic mice.
Volume: 33
Issue: 3
Pages: 624.e23-34
•
•
•
•
•
Publication
18490011 | J:137947
First Author: Rosenmann H
Year: 2008
Journal: Exp Neurol
Title: A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Volume: 212
Issue: 1
Pages: 71-84
•
•
•
•
•
Publication
18621045 | J:138856
First Author: Uusi-Rauva K
Year: 2008
Journal: Exp Cell Res
Title: Novel interactions of CLN3 protein link Batten disease to dysregulation of fodrin-Na+, K+ ATPase complex.
Volume: 314
Issue: 15
Pages: 2895-905
•
•
•
•
•
Publication
35501917 | J:332722
First Author: Brody AH
Year: 2022
Journal: Mol Neurodegener
Title: Alzheimer risk gene product Pyk2 suppresses tau phosphorylation and phenotypic effects of tauopathy.
Volume: 17
Issue: 1
Pages: 32
•
•
•
•
•
Publication
38365772 | J:347105
First Author: Takahashi H
Year: 2024
Journal: Nat Commun
Title: Reduced progranulin increases tau and α-synuclein inclusions and alters mouse tauopathy phenotypes via glucocerebrosidase.
Volume: 15
Issue: 1
Pages: 1434
•
•
•
•
•
Publication
38712317 | J:350520
First Author: Sultanakhmetov G
Year: 2024
Journal: Brain Commun
Title: Mark4 ablation attenuates pathological phenotypes in a mouse model of tauopathy.
Volume: 6
Issue: 3
Pages: fcae136
•
•
•
•
•
Publication
31572168 | J:284224
 
First Author: Dunn-Meynell AA
Year: 2019
Journal: Front Aging Neurosci
Title: In vivo Bioluminescence Imaging Used to Monitor Disease Activity and Therapeutic Response in a Mouse Model of Tauopathy.
Volume: 11
Pages: 252
•
•
•
•
•
Publication
29016855 | J:250504
First Author: Woo JA
Year: 2017
Journal: Hum Mol Genet
Title: Enhanced tau pathology via RanBP9 and Hsp90/Hsc70 chaperone complexes.
Volume: 26
Issue: 20
Pages: 3973-3988
•
•
•
•
•
Publication
35662390 | J:342181
First Author: Ono M
Year: 2022
Journal: Aging Cell
Title: Central role for p62/SQSTM1 in the elimination of toxic tau species in a mouse model of tauopathy.
Volume: 21
Issue: 7
Pages: e13615
•
•
•
•
•
Publication
29117258 | J:249269
First Author: Gahring LC
Year: 2017
Journal: PLoS One
Title: Lung epithelial response to cigarette smoke and modulation by the nicotinic alpha 7 receptor.
Volume: 12
Issue: 11
Pages: e0187773
•
•
•
•
•
Publication
29995210 | J:289241
First Author: Khan SS
Year: 2018
Journal: Acta Neuropathol
Title: Bidirectional modulation of Alzheimer phenotype by alpha-synuclein in mice and primary neurons.
Volume: 136
Issue: 4
Pages: 589-605
•
•
•
•
•
Publication
17486104 | J:122104
First Author: Plachta N
Year: 2007
Journal: Nat Neurosci
Title: Identification of a lectin causing the degeneration of neuronal processes using engineered embryonic stem cells.
Volume: 10
Issue: 6
Pages: 712-9
•
•
•
•
•
Publication
25209291 | J:216289
First Author: Lee S
Year: 2014
Journal: J Neurosci
Title: Opposing effects of membrane-anchored CX3CL1 on amyloid and tau pathologies via the p38 MAPK pathway.
Volume: 34
Issue: 37
Pages: 12538-46
•
•
•
•
•
Publication
29862881 | J:264849
First Author: Barbero-Camps E
Year: 2018
Journal: Autophagy
Title: Cholesterol impairs autophagy-mediated clearance of amyloid beta while promoting its secretion.
Volume: 14
Issue: 7
Pages: 1129-1154
•
•
•
•
•
Publication
22427994 | J:224126
First Author: Suenaga K
Year: 2012
Journal: PLoS One
Title: Muscleblind-like 1 knockout mice reveal novel splicing defects in the myotonic dystrophy brain.
Volume: 7
Issue: 3
Pages: e33218
•
•
•
•
•
Publication
28484365 | J:276727
 
First Author: Vargas-Caballero M
Year: 2017
Journal: Front Neurosci
Title: Wild-Type, but Not Mutant N296H, Human Tau Restores Aβ-Mediated Inhibition of LTP in Tau-/- mice.
Volume: 11
Pages: 201
•
•
•
•
•
Publication
31599329 | J:293638
First Author: Carvalho K
Year: 2019
Journal: Brain
Title: Exacerbation of C1q dysregulation, synaptic loss and memory deficits in tau pathology linked to neuronal adenosine A2A receptor.
Volume: 142
Issue: 11
Pages: 3636-3654
•
•
•
•
•
Publication
24626633 | J:210986
First Author: Wisely EV
Year: 2014
Journal: Hum Mol Genet
Title: Genetic suppression of β2-adrenergic receptors ameliorates tau pathology in a mouse model of tauopathies.
Volume: 23
Issue: 15
Pages: 4024-34
•
•
•
•
•
Publication
37791598 | J:355486
First Author: Marino C
Year: 2024
Journal: Alzheimers Dement
Title: APOE Christchurch-mimetic therapeutic antibody reduces APOE-mediated toxicity and tau phosphorylation.
Volume: 20
Issue: 2
Pages: 819-836
•
•
•
•
•
Publication
30415998 | J:269834
First Author: Litvinchuk A
Year: 2018
Journal: Neuron
Title: Complement C3aR Inactivation Attenuates Tau Pathology and Reverses an Immune Network Deregulated in Tauopathy Models and Alzheimer's Disease.
Volume: 100
Issue: 6
Pages: 1337-1353.e5
•
•
•
•
•
Publication
18951953 | J:144874
First Author: Engel T
Year: 2008
Journal: Neuroscience
Title: Hippocampal neuronal subpopulations are differentially affected in double transgenic mice overexpressing frontotemporal dementia and parkinsonism linked to chromosome 17 tau and glycogen synthase kinase-3beta.
Volume: 157
Issue: 4
Pages: 772-80
•
•
•
•
•
Publication
24936619 | J:284792
First Author: Wang B
Year: 2014
Journal: J Neurosci Res
Title: Low-dose total-body carbon-ion irradiations induce early transcriptional alteration without late Alzheimer's disease-like pathogenesis and memory impairment in mice.
Volume: 92
Issue: 7
Pages: 915-26
•
•
•
•
•
Publication
21976528 | J:177434
First Author: Carroll JC
Year: 2011
Journal: J Neurosci
Title: Chronic stress exacerbates tau pathology, neurodegeneration, and cognitive performance through a corticotropin-releasing factor receptor-dependent mechanism in a transgenic mouse model of tauopathy.
Volume: 31
Issue: 40
Pages: 14436-49
•
•
•
•
•
Publication
31951013 | J:297504
First Author: Hou TY
Year: 2020
Journal: J Neurochem
Title: Correcting abnormalities in miR-124/PTPN1 signaling rescues tau pathology in Alzheimer's disease.
Volume: 154
Issue: 4
Pages: 441-457
•
•
•
•
•
Publication
22096518 | J:180977
First Author: Platt B
Year: 2011
Journal: PLoS One
Title: Abnormal cognition, sleep, EEG and brain metabolism in a novel knock-in Alzheimer mouse, PLB1.
Volume: 6
Issue: 11
Pages: e27068
•
•
•
•
•
Publication
36092803 | J:329014
 
First Author: Zheng XY
Year: 2022
Journal: Front Aging Neurosci
Title: Levetiracetam alleviates cognitive decline in Alzheimer's disease animal model by ameliorating the dysfunction of the neuronal network.
Volume: 14
Pages: 888784
•
•
•
•
•
Publication
19020019 | J:142367
First Author: Ji B
Year: 2008
Journal: J Neurosci
Title: Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologies.
Volume: 28
Issue: 47
Pages: 12255-67
•
•
•
•
•
Publication
26239174 | J:232259
First Author: Jyoti A
Year: 2015
Journal: Neurobiol Aging
Title: Progressive age-related changes in sleep and EEG profiles in the PLB1Triple mouse model of Alzheimer's disease.
Volume: 36
Issue: 10
Pages: 2768-84
•
•
•
•
•
Publication
27230293 | J:284816
 
First Author: Domise M
Year: 2016
Journal: Sci Rep
Title: AMP-activated protein kinase modulates tau phosphorylation and tau pathology in vivo.
Volume: 6
Pages: 26758
•
•
•
•
•
Publication
33712083 | J:311555
First Author: Bajracharya R
Year: 2021
Journal: Acta Neuropathol Commun
Title: Tau antibody isotype induces differential effects following passive immunisation of tau transgenic mice.
Volume: 9
Issue: 1
Pages: 42
•
•
•
•
•




MouseMine is a collaboration between MGI at The Jackson Laboratory and the InterMine project at the Cambridge Systems Biology Centre. MouseMine is funded through a grant from the NIH/NHGRI.The Jackson Laboratory makes no representation about the suitability or accuracy of this software or data for any purpose, and makes no warranties, either express or implied, including merchantability and fitness for a particular purpose or that the use of this software or data will not infringe any third party patents, copyrights, trademarks, or other rights. the software and data are provided "as is". This software and data are provided to enhance knowledge and encourage progress in the scientific community and are to be used only for research and educational purposes. Any reproduction or use for commercial purpose is prohibited without the prior express written permission of the Jackson Laboratory.

Copyright © 2017 by The Jackson Laboratory. All Rights Reserved

© 2002 - 2017 Department of Genetics, University of Cambridge, Downing Street,
Cambridge CB2 3EH, United Kingdom